西格医学 (873450.OC)

+ 收藏

现金流量表(西格医学)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 43,691,848.4163,430,788.1330,266,056.9754,355,145.6325,114,000.67
 收到其他与经营活动有关的现金(元) 181,881.962,009,933.83384,199.781,011,290.15173,161.82
 经营活动现金流入小计(元) 43,873,730.3765,440,721.9630,650,256.7555,366,435.7825,287,162.49
 购买商品、接受劳务支付的现金(元) 12,830,463.5713,068,632.728,130,877.679,460,161.972,688,958.29
 支付给职工以及为职工支付的现金(元) 13,418,604.0921,015,982.0511,111,196.6719,005,360.3810,065,421.78
 支付的各项税费(元) 5,510,948.046,721,574.444,416,128.453,460,318.992,101,376.28
 支付其他与经营活动有关的现金(元) 2,739,910.925,381,900.912,326,037.404,613,137.652,193,968.12
 经营活动现金流出小计(元) 34,499,926.6246,188,090.1225,984,240.1936,538,978.9917,049,724.47
 经营活动产生的现金流量净额(元) 9,373,803.7519,252,631.844,666,016.5618,827,456.798,237,438.02
二、投资活动产生的现金流量
 收回投资收到的现金(元) 54,471,000.0075,574,519.3045,940,142.7364,904,600.00-
 取得投资收益收到的现金(元) 105,039.411,520,159.011,039,771.381,468,677.92468,347.48
 收到其他与投资活动有关的现金(元) -2,800,000.00-3,300,000.009,400,000.00
 投资活动现金流入小计(元) 54,576,039.4179,894,678.3146,979,914.1169,673,277.929,868,347.48
 购建固定资产、无形资产和其他长期资产支付的现金(元) 140,283.00389,301.86341,625.001,178,844.176,399.00
 投资支付的现金(元) 64,939,151.6063,287,000.0033,500,000.0080,083,000.00-
 支付其他与投资活动有关的现金(元) -2,800,000.00-3,421,432.5922,500,000.00
 投资活动现金流出小计(元) 65,079,434.6066,476,301.8633,841,625.0084,683,276.7622,506,399.00
 投资活动产生的现金流量净额(元) -10,503,395.1913,418,376.4513,138,289.11-15,009,998.84-12,638,051.52
三、筹资活动产生的现金流量
 取得借款收到的现金(元) 1,000,000.009,000,000.002,000,000.0014,000,000.008,000,000.00
 筹资活动现金流入小计(元) 1,000,000.009,000,000.002,000,000.0014,000,000.008,000,000.00
 偿还债务支付的现金(元) 1,000,000.0020,000,000.005,000,000.0011,000,000.005,000,000.00
 分配股利、利润或偿付利息支付的现金(元) 6,623,125.0010,875,747.2510,790,960.967,647,301.36201,305.72
 支付其他与筹资活动有关的现金(元) 213,650.00821,275.00399,261.00645,888.10-
 筹资活动现金流出小计(元) 7,836,775.0031,697,022.2516,190,221.9619,293,189.465,201,305.72
 筹资活动产生的现金流量净额(元) -6,836,775.00-22,697,022.25-14,190,221.96-5,293,189.462,798,694.28
五、现金及现金等价物净增加额(元) -7,966,366.449,973,986.043,614,083.71-1,475,731.51-1,601,919.22
 加:期初现金及现金等价物余额(元) 15,204,547.595,230,561.555,230,561.556,706,293.066,706,293.06
 期末现金及现金等价物余额(元) 7,238,181.1515,204,547.598,844,645.265,230,561.555,104,373.84
补充资料:
 净利润(元) 9,216,735.9017,944,563.509,063,172.7717,427,162.084,892,988.81
 固定资产和投资性房地产折旧(元) 143,062.29240,447.10121,886.37135,733.2460,847.54
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 143,062.29240,447.10121,886.37135,733.2460,847.54
 长期待摊费用摊销(元) 49,126.20100,926.0451,799.8430,396.422,916.66
 固定资产报废损失(元) ---12,019.07-
 公允价值变动损失(元) 2,000,000.003,117,945.21-754,895.54-1,094,377.62-511,405.85
 财务费用(元) 22,840.95305,470.78205,014.24470,204.11213,329.88
 投资损失(元) -103,442.41-553,815.48-156,076.78-704,926.79-422,584.61
 递延所得税(元) -465,753.25-849,977.26-156,759.3895,962.0620,844.78
  其中:递延所得税资产减少(元) -465,753.25-684,717.37-134,750.72-69,297.8320,844.78
 递延所得税负债增加(元) --165,259.89-22,008.66165,259.89-
 经营性应收项目的减少(元) -1,311,651.66-11,972,855.95-728,941.91-2,250,994.042,081,415.15
 经营性应付项目的增加(元) -1,870,684.208,742,675.35-4,073,434.033,651,499.801,771,632.58
 现金的期末余额(元) 7,238,181.1515,204,547.598,844,645.265,230,561.555,104,373.84
 减:现金的期初余额(元) 15,204,547.595,230,561.555,230,561.556,706,293.066,706,293.06
 现金及现金等价物的净增加额(元) -7,966,366.449,973,986.043,614,083.71-1,475,731.51-1,601,919.22
公告日期 2024-08-162024-04-252023-08-092023-03-172022-08-19
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院